Connect with us

Stocks to Watch

Investors See New Opportunity In Sports Technology: Cognitive Tech Industry Worth $7.5 Billion & This Company Has The Winning Strategy

Joe Samuel

Published

on

It may seem like stating the obvious but for athletes of all skill levels, there is always room for improvement, and right now investors could have the opportunity to score big. An individual’s athletic ability is traditionally measured by their speed, strength, agility, and endurance. Rarely is one’s cognitive development taken into consideration with their capacity to perform.

Take, for example, a Major League Baseball player, standing at home plate, ferociously awaiting their home-run pitch. From the time the pitcher throws a 95-mph fastball until it gets to the plate is roughly 430 milliseconds. On average, it takes 150 milliseconds for a Major Leaguer to get their bat around, leaving tens of milliseconds on the middle to decree whether to swing or not.

If the batter manages to connect with the ball, it’s based on the player’s years in developing the processing speed and reaction time needed to hit that ball; both are factors of cognitive development. Cognitive assessment technology for professional athletic development represents a multi-billion dollar industry that is piping hot with investor opportunities. As athletes recognize a never-before-seen realm of competitive edge over their opponents, one company, in particular, has what it takes to get ahead of the ball and connect.

ESPN Says That This Is A True First! XSport Global, Inc. (XSPT) Knows The Future Of Peak Performance & Investors Could Score Big Points!

Every seasoned athlete knows that every sport, be it basketball or golf, is ultimately a test of cognition. When we watch NBA players like Lebron James hit a game-winning 3-pointer or professional golfers like Tiger Woods putt their way to a PGA trophy, rarely do we consider their mental toughness and ability to perform under stress.

technology stockEnter XSport Global, Inc. (XSPT). This company is leading the cognitive assessment technology industry as they seek to further the success of high-performance athletes around the world through “leading sciences, innovative technologies, and pioneering digital media.”

The opportunity that XSport (XSPT) presents right now could be unparalleled as the market is wide open for this technology to take hold. Keep in mind that all of this is happening while XSport is showing no signs of slowing down. In September 2017, XSport (XSPT) strategically acquired Head Trainer, Inc; an innovative tech company focused on improving cognitive functioning for high-performance athletes through the use of their user-friendly mobile applications.

ESPN Senior Writer, Darren Rovell said[i] the HeadTrainer app “is the first sports-based app and offers to train the brain in the areas of focus and concentration, visual and spatial awareness, processing speed, memory, and decision-making.”

But unlike other sports technology and app development companies, HeadTrainer already has a laundry list of athletes endorsing the technology! Philadelphia Phillies outfielder Jose Bautista, golfer Rickie Fowler, racecar driver Dale Earnhardt Jr., football player Richard Sherman, and soccer player Alex Morgan, among others, are endorsing the new tool.

“Everyone is looking for that edge there’s only so far you can go with talent and your physical traits…The mental part of the game is the hardest to explain because you can feel it and, the sense was that until now you couldn’t practice it like having pitches thrown to you or fielding fly balls.”

– Jose Bautista, Philadelphia Phillies

Brain Training Is Important, And Investors Should Pay Attention Now

XSport (XSPT), through the acquisition of Head Trainer, Inc. and their powerful mobile app, is creating an opportunity for athletes around the world to reach their full potential and take rise above the competition in their sports.

As the awareness of brain fitness rises among individuals and professional athletes, the demand for cognitive development technology increases. According to their official website, the Head Trainer app is designed to “engage and improve cognitive skills in five key area: Focus/Concentration, Visual-Spatial Awareness, Decision Making, Memory and Processing Speed.”

Cognitive skills are the core skills that the brain uses to think, learn, and, in the case of sports, perform. If professional athletes want to strengthen their game, they need to strengthen their mind, and the Head Trainer App, backed by XSport, is the key to unlocking an athlete’s peak mental capacity.

According to a recent market research report[ii] published by cognitive assessment industry professionals, the global assessment and training market is set to grow from $1.98 billion in 2018 to $8.06 billion by 2021, at a “Compound Annual Growth Rate (CAGR) of 32.3%. Current cognitive training systems are generally designed for non-athletic training where a subject is in a calm, quiet environment. Along including traditional sight and touch cognitive training modules, XSport (XSPT), by contrast, is building its technology around replicating a true sporting event environment.

For instance, XSport (XSPT) can incorporate outside and background noise in future releases. By utilizing headphones with environment-specific, programmed noise, audio tracks, and prompts, the company has created its product with an integrated audio track, sight, touch, and sound training systems that allows the athlete to train in an environment that is similar to the actual competition. This fact alone could set XSport (XSPT) above and beyond its competition.

And the writing could already be on the wall for investors. The Brain Health Devices Market is expected to have a profoundly favorable outlook for the next five years 2018-2026 according to a recently released Brain Health Devices Market research report[iii]. Part of this growth is expected to be fueled by significant market developments like mergers and acquisitions. Big deals are already being struck.

For example, Vivity Labs Inc., the makers of Fit Brains Trainer, which offers a suite of brain-training exercises, was acquired by Rosetta Stone for $12 million[iv]. And though full details have not been disclosed, Hachette Livre, a company that delivered revenue of €2.289B in 2017, acquired a majority stake in Brainbow, which created its brain training application for non-sports based cognitive education[v].

The momentum is evident, and now XSport (XSPT) could be presenting a unique opportunity in the market specifically for cognitive function in sports applications.

Know Thy Self, Know Thy Enemy. A Thousand Battles, A Thousand Victories

Every coach worth their weight in wisdom knows that the key to beating the competition is extensive knowledge of their strengths and weaknesses. In one of their recent annual fiscal reports[vi], Head Trainer, Inc., indicated that they were well aware of several companies in the industry that have developed rudimentary versions of cognitive training platforms, but believe that their product is far superior.

XSport’s biggest rival in the cognitive assessment space is Cogstate Ltd a science and technology solutions company based in Australia. The company’s goal, according to their official site, is to “invest in enhanced solutions to meet the current and future needs of clinical trials in central nervous system indications.”

While this is admirable and will benefit approaches to cognitive medicine, Cogstate’s short-sighted vision comes nowhere close to rapidly growing industry surrounding the application of cognitive assessment for athletes. This narrow focus seeks to “simplify the measurement of cognition,” and nothing else.

Market analysts looking at the cognitive assessment market should take this as an indication that there may be nothing standing in the way of XSport’s (XSPT) dominance over the sector. Don’t just limit the company to its strategic investment in the improvement of athletic mental performance either.

XSport (XSPT) Strategically Advances Into Corporate Holding Space Through Acquisition and Partnership with Shift Now, Inc.

Like any large market leader in their respective field, XSport (XSPT) is taking a strategic approach to the market and ensuring that it can handle a full-scale sports technology and media holding business. This is all while remaining focused on developing “disruptive sports-centric technologies and related media projects around the world.”

In early September 2018, XSport (XSPT) announced the acquisition of the Greensboro-based, brand agency, Shift Now, Inc., a “full-service creative and digital marketing” firm.

“With the acquisition of Shift Now, a profitable and scalable revenue generating firm, coupled with the outstanding team of professional employees Kristi Griggs has attracted, we now have our own leading agency to magnify our brands and transform the overall market. This highly complementary acquisition of Shift Now will serve as the foundation for XSport Global to develop our brands for the youth sports market without having to pay the high-margin, billable hours of outside creative agencies.” -Robert Finigan, CEO of XSport Global

The deal gives XSport (XSPT) round-the-clock access to innovative approaches to marketing and will allow for Head Trainer, Inc. and XSport’s other holdings to strategically reach market investors, and target desired audiences.

As XSport (XSPT) shifts their focus to building out their corporate holdings, the addition of Shift Now, Inc with more than $3 million in annual revenue, presents an opportunity that can be vertically integrated into their business model. With investment potential growing by the second, XSport is designing their corporate infrastructure to be scalable and adaptive to the needs of consumers and market investors alike.

XSport (XSPT): Built By A Leading Roster Of Industry Professionals

XSport (XSPT) has been built and is being led by a team driven by success. Dr. Brian Monteleone, a Charlotte-based sports psychologist, helped build the framework for HeadTrainer. During his 25 year career, Dr. Monteleone has worked in private practice, as a sports psychologist, Clinical Coordinator for an inpatient psychiatric and substance abuse hospitals, Clinical Director of a federally funded juvenile boot camp program, and counselor in a residential treatment center for dually-diagnosed adolescents.

In addition to Monteleone, Dr. Claude T. Moorman, III helped lead the charge to develop the specific sports-themed challenges that would be fun while also testing the brain’s vital cognitive areas. With the goal of getting people to recognize that cognition is a huge part of performance, the team designed a platform geared toward sharpening cognitive abilities specific to sports.

Once a team doctor for the Baltimore Ravens, Dr. Claude Moorman, also has a wealth of experience tending to athletes at the highest levels. Atrium Health, previously Carolinas HealthCare System, named Claude “T.” Moorman, III, MD as the new president of Atrium Health’s musculoskeletal institute and The Edward N. Hanley, Jr. Endowed Chair of the Department of Orthopedic Surgery.

headtrainer logo

Dr. Moorman also served as executive director of the James R. Urbanski Sports Sciences Institute at Duke University Medical Center, professor and vice chairman of the Department of Orthopedics and head team physician for Duke University Athletics.

Robert Finigan, XSport’s (XSPT) Chief Executive Officer, has a reputation in brand development that speaks for itself. Throughout his career, Finigan has served in various C-level roles for global companies in technology, health and Wellness and Media, in addition to several consulting and strategy firms, and has been recognized for many award-winning brand identity initiatives.

Robert also recognizes the importance of giving back to the community. In recent years, Finigan has served as President of the Heart and Soul Foundation; a 501(3)c focused on supporting and redefining music education. Finigan’s consumer and industry savvy, coupled with the vision of XSport, gives the company that competitive advantage that it needs to succeed.

Furthermore, Hank Durschlag is the Founder and Chairman of the Board of Directors of HeadTrainer, Inc. Mr. Durschlag previously served a President of Double Eagle Holdings, LLC, and as CEO of HealthSport, Inc., both R&D companies involved in the development of nutraceutical and other products for professional and amateur athletes. Hank was a founding partner and served as President of GlucoTec, Inc. (now Glytec Systems), a developer of FDA-approved software related to intravenous dosing of medications and other fluids.

Mr. Durschlag was also the Vice President of Sales & Marketing for Diabetes Management Services, Inc. (DMS), a national diabetes products and service company with treatment modules focusing on acute care, and women’s health. Hank received a Bachelor’s Degree from California University of Pennsylvania, California, PA, and a Master’s Degree in Business Administration from Clemson University, Clemson, SC.

Funds Give Vote Of Confidence To XSport (XSPT)

During the middle of the fourth quarter, XSport (XSPT) reached yet another major milestone in attracting notable backing from an up and coming fund. TRITON FUNDS was started by three undergraduate students from Southern California aspiring to create an investment fund with a millennial touch. In November, the Fund inked a deal with XSport (XSPT) to push up to another $1 million in development capital into the company. And in their own words, the leadership of TRITON appears to be more than happy to be able to get an early opportunity with this company:

“We continue to seek out the best investment opportunities and XSport Global represents the type of early-stage, growth company we intend to add to our portfolio of investments. We believe their business acumen and strategy is sound, and we are confident with the tremendous upside potential in the multi-billion dollar cognitive sports training industry. We look forward to working together.” – Yash Thukral, Founder of TRITON FUNDS.

“A management team that is highly motivated in seeing through the Company’s vision is something we here at TRITON FUNDS highly emphasize, and Robert Finigan provided just that for XSPT,” added Dmitriy Slobodskiy, Junior Partner, of TRITON FUNDS. “As a millennial fund, we pride ourselves in working with companies such as XSport Global who directly affect our generation as well as the youth in providing new technology and insight in an ever-changing space.”

The Game Has Only Just Begun

Old school agents and young reporters have recently shifted focus on what the next “Moneyball phenomena” will be. Mental, emotional, and health metrics are some of the common data points that these thinkers forecast will be part of the next sports analytical movement.

XSport (XSPT), backed by a roster of professional athletes and brand ambassadors, is leading the cognitive assessment industry to help athletes achieve their full potential. With HeadTrainer, Inc. and their mobile application, XSport (XSPT) can rise above the rest.

What separates HeadTrainer from other “brain-training” apps is not only the sports-themed user experience but the robust audio and video components – incorporating interactive messages and positive reinforcement from some of the top athletes in sports along with distractive sounds to help enhance the focus and concentration component of training.

“If I can process information faster and make decisions sooner, I can react quicker, and that can be the difference between a first down for my opponent or a pick-six for my team. The smart player wins.” – Richard Sherman, NFL Seattle Seahawks, San Francisco 49ers

With rapid advancements in technology, the adoption of cognitive assessment solutions is expected to result in massive market growth opportunities in the next five years. Because of the growing need for professional athletes to enhance their cognitive functions and annihilate their competition, this technology could build out its own niche within the sector.

The next big boom in the sports performance industry is technology designed to improve cognitive functions. Young athletes entering the professional levels of their sports are failing to recognize the importance of brain development. Factors like decision-making, processing speed, visual-spatial awareness, and reaction time will separate athletes from the pack, and XSport (XSPT) could lead athletes and investors to victory.

 

stock market home run

 

End Notes:

[i] Darren Rovell: http://www.espn.com/espn/story/_/id/13086476/brain-training-gaining-momentum-new-app-athletes-unveiled

[ii] Market research report: https://www.marketsandmarkets.com/Market-Reports/cognitive-assessment-market-1039.html

[iii] Brain Health Research Report https://www.industrychronicle.com/brain-health-devices-market-exclusive-analysis-by-industry-recent-trends-size-and-forecast-up-to-2026/

[iv] Rosetta Stone acquires Vivity Labs https://www.fastcompany.com/3023881/rosetta-stone-buys-brain-training-app-seeks-to-expand-beyond-language-learning

[v] Hachette Livre acquisition of majority stake in Brainbow https://www.forbes.com/sites/ellenduffer/2016/12/31/hachette-livre-acquires-majority-stake-in-brainbow/

[vi] XSPT Financial report: https://www.sec.gov/Archives/edgar/data/1628104/000114036118014328/form10k.htm

DISCLAIMER: Pursuant to an agreement between MIDAM VENTURES, LLC an affiliate of JSG COMMUNICATIONS LLC and XSport Global, Inc. we were hired for a period from 11/4/2018 – 2/4/2019 to publicly disseminate information about XSport Global, Inc. including on the Website and other media including Facebook and Twitter. We were paid $50,000 (CASH) for & were paid “0” shares of restricted common shares. We own zero shares of XSport Global, Inc., which we purchased in the open market. We may buy or sell additional shares of XSport Global, Inc. in the open market at any time, including before, during or after the Website and Information, provide public dissemination of favorable Information. Click Here For Full Disclaimer

Continue Reading
Click to comment

Featured

Amazon (AMZN) Moves Out Of the US Food-Delivery Business; New Opportunities For Growth

Joe Samuel

Published

on

marijuana stocks to watch April

Will This Signal New Opportunities For Other Delivery Tech Companies?

E-commerce giant Amazon (AMZN) is well known for entering new businesses if they see an opportunity and hence, it was not a surprise when it entered the booming food delivery business with Amazon Restaurants. It was launched back in 2015, but the company has not decided to shut down the business altogether.

[Report] Could This Company Take Over Next Now That Amazon Is Gone?

The service had first been launched in Seattle but then launched in a string of other major cities in the United States and also London in the United Kingdom. The U.K. operation was closed in December last year and now the business in the U.S. is also set to be closed. The service had been bundled with Amazon Prime and customers who had the subscription could avail the Amazon Restaurants service at no extra cost.

Tough Business

The food delivery sector might be a booming one thanks to the billions of dollars that have been invested into companies by venture capitalists, but it remains a tough business to thrive in. The cost of hiring workers to make the deliveries and offering promotions frequently to lure customers can erode capital pretty fast.

Amazon had offered a $10 discount from the first order placed on Amazon Restaurants for instance. The profit margins in food delivery are notoriously thin and the logistics of the business can prove to be extremely complex.

Considering the fact that the online good delivery business had evolved into a multibillion-dollar industry, it was hardly surprising that Amazon had decided to enter it. As a company, Amazon has had plenty of setbacks of this nature despite being a company that revels in logistical challenges.

More Than Just Food: How Companies Are Evolving The Industry

Companies like ParcelPal (PTNYF) (PKG) have created an on-demand marketplace where customers can shop for anything from food to clothes. There is no more waiting in line for lunch or rushing to the store after work to grab your clothes. With ParcelPal on-demand, customers simply shop from the app, choose the items they want, and pay.

Something that is beginning to set ParcelPal (PTNYF) (PKG) apart from its immediate competition is its diversification strategy. Not only is the company working with the likes of Amazon, but it is also entering into key verticals that are seeing an increase in rapid demand. Right now, ParcelPal has built relationships with businesses in both alcohol and cannabis. Don’t Believe Us? Click Here For More.

About Amazon’s Food Delivery

For instance, Amazon had launched its grocery delivery service around 10 years ago but struggled to make it work. Eventually, the company acquired Whole Foods two years ago for $13.7 billion in order to truly turbocharge its grocery delivery business. Hence, it would be presumptuous to say that Amazon’s exit from Amazon Restaurants is a definitive exit from the food delivery space.

In this regard, it is important to note that the Jeff Bezos led company has already led a massive $575 million funding round for U. K. based food delivery startup Deliveroo this year.

That is a clear indication that Amazon is definitely going to be in the food delivery space in the long run and it would be interesting to see whether the company acquires a U. S. food delivery business following the closure of Amazon Restaurants. It is being speculated that Amazon might try to acquire GrubHub in its quest to get a toehold in the U. S. food delivery sector.

GrubHub and ParcelPal stock have continued to climb after the Amazon news was released.

delivery stocks to buy
Disclaimer: MIDAM VENTURES LLC has been compensated $75,000 per month by a ParcelPal Technology, Inc. for a period beginning September 1, 2018 and ending February 1, 2019 to publicly disseminate information about (PTNYF/PKG) to publicly disseminate information about (PTNYF/PKG). Midam Ventures has been compensated $100,000 by Parcel Pal and has extended coverage to April 1, 2019. Midam Ventures has been compensated $100,000 by Parcel Pal and has extended coverage to May 1, 2019. Midam Ventures has been compensated $200,000 by Parcel Pal and has extended coverage to June 1, 2019. Midam Ventures has been compensated $200,000 by Parcel Pal and has extended coverage to July 1, 2019. We may buy or sell additional shares of (PTNYF/PKG) in the open market at any time, including before, during or after the Website and Information, provide public dissemination of favorable Information. We own zero shares. Click Here For Full Disclaimer

Continue Reading

Biotechnology

4 Biotech Stocks To Watch After Latest M&A Activity

Joe Samuel

Published

on

biotech stocks to buy now

This month the American Society of Clinical Oncology held its annual meeting in Chicago, which brought about more attention to the healthcare sector and biotech stocks. The recent deal between Merck and Tilos Therapeutics has sparked increased enthusiasm within the industry.  The takeover will give Merck control of a pipeline of cancer, fibrosis and autoimmune programs targeting the latent TGFβ complex.

Cancer research remains one of the most critical areas of focus for most investors. This is simply due to the fact that if a company can come up with a truly path-breaking product, then the potential for growth could be significant. With this in mind, here are four biotech stocks to watch on Tuesday.

Small Cap Biotech Stocks Take Center Stage

GT Biopharma (GTBP) has followed suit with a clear focus on immune diseases.  The company’s lead treatment, GTB-1550 is a novel multi-target directed therapy for the treatment of chemotherapy-refractory B-cell malignancies, including Non-Hodgkins Lymphoma and Leukemia.  “GTB-1550 has shown positive results in its two Phase I-II clinical trials in advanced cancer patients who have failed all other therapies, and we are now planning to proceed with a Phase II clinical trial,” explained Anthony Cataldo, the Chairman and Chief Executive Officer of GT Biopharma.

Mr. Cataldo took the reigns on GT Biopharma earlier this year.  He is the founder of the company and one of the key leaders within the industry. His past successes include being the founder and previous CEO of Iovance Biotherapeutics. Anthony Cataldo was able to grow Iovance early on, and the company currently holds a market cap of over $2 billion with a share price above $19 per share.

In addition to the above, the company’s therapy has also shown that it could target HIV infected cells in the University of Minnesota’s preclinical testing. Not only that but in specific tests, data showed that HIV-infected targets that express the HIV envelope on their surface could be eliminated. As the company stated, “The HIV TriKE’s possibility to kill the HIV virus would solve a massive economic burden as well as stop infected patients from spreading the disease.”

Adding to this list of novel biotech stocks to watch, Histogenics Corporation (HSGX) is targeting a pipeline of therapies to treat rare eye diseases.  In April, the company announced a deal with Ocugen Inc. to ultimately take over the company. Ocugen was founded by Pfizer’s Shankar Musunuri and University of Colorado professor Uday Kompella. According to reports, once the merger is complete, Ocugen will try to sell Histogenics’ NeoCart, which is its regenerative treatment designed to treat knee cartilages. HSGX shares saw a jump on Tuesday to highs of nearly $0.23 and have been in an uptrend for the last three trading sessions. 

“Since Ocugen’s founding, we have sought to develop innovative therapies to treat rare and underserved eye diseases through a combination of therapeutic approaches that utilize small molecules, biologics, and gene therapies,” said Shankar Musunuri, Ph.D., M.B.A., Chairman, Chief Executive Officer and Co-Founder of Ocugen.

Big Moves On Penny Stock News

Further to the focus on eye care, NovaBay (NBY) stock has taken on a bright light this week. Since making headlines on Monday, shares of the company have jumped from a close of $0.32 last Friday to highs of $4.78 during Tuesday’s premarket session.  This move of nearly 1,400% comes as the company reported that its Avenova eye-care product is now available without a prescription on Amazon.com through its new direct-to-consumer online channel.

“While prescription Avenova continues to be available through retail pharmacies and direct in-office sales by certain eye care specialists, patients and physicians have asked for greater accessibility to the product,” said NovaBay Chief Executive Justin Hall. “In response, we are launching our new U.S. direct-to-consumer channel, which is a significant step in ensuring easy access at an affordable price.”

A Pop & Drop For Others?

Shares of SINTX Technologies, Inc (SINT) have also begun to rally this week.  The move has come after announcing the renewal of its lease with Portfolio Investments at Centrepointe Business Park for a five-year term. Shares are up by more than 50% since Monday afternoon. 

Dr. Sonny Bal, President & CEO, said, “This is a milestone for SINTX. We have right-sized our operations, and the significant cost savings from the building lease will allow SINTX to focus on scaling up our manufacturing, and invest further in R&D activities.”

As the company explains, “The core strength of SINTX Technologies is the research and development of medical-grade silicon nitride ceramics for external partners. The Company presently manufactures silicon nitride spinal implants in its FDA registered and ISO 13485 certified manufacturing facility for CTL-Amedica, the exclusive retail channel for silicon nitride spinal implants.”

Finally, Midatech Pharma Plc (MTP) saw its stock rise on Tuesday morning.  After closing the previous week near June lows of $1.20, MTP shares have jumped as high as $1.73 this week.  The move comes after the company received a patent titled “Nanoparticle Delivery Compositions.” These will specifically be used to target biologically active agents in the central nervous system.

The company itself focuses on patients with rare and serious cancers. Furthermore, the company’s therapies look to improve bio-delivery and bio-distribution of medicines or agents to areas of the body where they are needed and can exert their actions in an effective, safe, and precise manner.

biotech stock to buy 2019
Pursuant to an agreement between MIDAM VENTURES, LLC and GT Biopharma, Midam was hired for a period from 06/07/2019 – 7/07/2019 to publicly disseminate information about GT Biopharma including on the Website and other media including Facebook and Twitter. We were paid $100,000 (CASH) for & were paid “0” shares of restricted common shares. We may buy or sell additional shares of GT Biopharma in the open market at any time, including before, during or after the Website and Information, provide public dissemination of favorable Information. Click Here For Full Disclaimer.

Continue Reading

Featured

StockPrice Morning Update, Stock Market News & More – June 11, 2019

Joe Samuel

Published

on

stock market news june

Biotech & Cancer Research Ignite New Interest In Healthcare Stocks

Over the past decades, cancer research has become one of the most important segments in the biotech and pharmaceutical industries. Consequently, the advances made in the field have been considerable and there are plenty of companies which have led the way with path-breaking findings.

Click Here For Full Article


In Case You Missed It:
Anthony T. Sleiman Joins Liberty Defense’s (SCAN) Board of Advisors

VANCOUVER and ATLANTA , June 10, 2019 /CNW/ – Liberty Defense Holdings Ltd.(“Liberty“) (TSXV: SCAN; FRANKFURT : LD2) is pleased to announce that Anthony T. Sleiman , CEO and President of Sleiman Enterprises, Inc. (“Sleiman Inc.”), has joined the company’s advisory board.

Click Here To Read This Big Announcement


Amazon’s Ad-Biz On A Roll Amid Increased Competition

Amazon.com, Inc. (AMZN), the giant e-marketer, the third-largest digital advertisement seller seems to be on the way of making it to the top. The Q1 advertising revenue, although not specifically mentioned in the annual reports, stood at $2.72 billion.

Continue Reading, Click Here


Disclaimer: Pursuant to an agreement between MIDAM VENTURES, LLC and Liberty Defense Holdings Inc. Midam was hired for a period from 04/15/2018 – 5/15/2019 to publicly disseminate information about Liberty Defense Holdings Inc. including on the Website and other media including Facebook and Twitter now extended through 6/21/2019. We were paid $350,000 (CASH) for & were paid “0” shares of restricted common shares. We may buy or sell additional shares of Liberty Defense Holdings Inc. in the open market at any time, including before, during or after the Website and Information, provide public dissemination of favorable Information. Click Here For Full Disclaimer

Continue Reading

Join Our Newsletter

Get stock alerts, news & trending stock alerts straight to your inbox!


We keep all user information pricate & promise to never spam.*

Privacy Policy

Search Stock Price (StockPrice.com)




Trending

Subscribe Now & Begin Receiving Free Stocks News, Articles, Trade Alerts & MORE, all 100% FREE!

We are your #1 source for all things Stock Market & Finance, Subscribe Below!

Privacy Policy: We will NEVER share, sell, barter, etc. any of our subscribers information for any reason ever! By subscribing you agree we can send you via email our free e-newsletter on stock market & finance related, articles, news and trade alerts. Further questions please contact privacy@stockprice.com